INCY
Incyte Corporation · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +4.8% ·
share flow +5.5% ·
net new positions +4.5%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 433.49K | $48.73M | n/a | n/a |
| Q2 2026 | 154 | 0 | 131.73M | $14.93B | +4 | −5 |
| Q1 2026 | 158 | +1 | 132.61M | $12.47B | +5 | −5 |
| Q4 2025 | 156 | -1 | 139.13M | $13.74B | +1 | −1 |
| Q3 2025 | 24 | 0 | 89.63M | $7.60B | n/a | −1 |
| Q2 2025 | 22 | +1 | 88.20M | $6.01B | +1 | n/a |
| Q1 2025 | 18 | -1 | 44.33M | $2.68B | n/a | −1 |
| Q4 2024 | 19 | +1 | 43.85M | $3.03B | +1 | n/a |
| Q3 2024 | 17 | 0 | 35.50M | $2.35B | +1 | −1 |
| Q2 2024 | 17 | n/a | 33.47M | $2.03B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 20.14M | n/a | $1.37B | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 17.96M | n/a | $1.22B | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 3 | Dodge & Cox ✦ | 14.60M | -1.8% | $993.93M | 0.6% | ▼ Trim | 5 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passive) | 9.88M | -1.6% | $672.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 8.20M | +21.8% | $558.52M | 0.5% | ▲ Add | 5 | SEC ↗ ×8 |
| 6 | Geode Capital Management ✦ (passive) | 4.35M | +3.3% | $294.90M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 3.88M | +4.7% | $264.36M | 0.4% | ▲ Add | 5 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 2.73M | +701.8% | $185.96M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 1.42M | +4.8% | $96.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | Marshall Wace ✦ | 1.21M | New | $82.48M | 0.1% | New | 1 | SEC ↗ ×3 |
| 11 | Fidelity (FMR) ✦ | 1.16M | n/a | $78.76M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 12 | Point72 Asset Management ✦ | 985.08K | +188.0% | $67.08M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 407.35K | -52.8% | $27.74M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | Bridgewater Associates ✦ | 394.08K | -37.2% | $26.84M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 230.79K | -51.6% | $15.72M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 16 | Gotham Asset Management ✦ | 187.82K | +65.4% | $12.79M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 17 | Millennium Management ✦ | 157.95K | -52.4% | $10.76M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | ARK Investment Management ✦ | 153.66K | -8.6% | $10.46M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 19 | Wellington Management ✦ | 75.86K | -6.2% | $5.17M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 20 | Two Sigma Investments ✦ | 64.35K | +12.9% | $4.38M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 29.92K | +74.6% | $2.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 3.57K | +357000.0% | $243,185 | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $82.48M | 0.1% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 805 holders, 201.47M shares, $18.13B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.64K sh · $297,780
Officer · 13.98K sh · $1.69M
Officer · 9.23K sh · $1.11M
Officer · 10.80K sh · $1.36M
Officer · 10.80K sh · $1.30M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology